Literature DB >> 20349406

ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications.

Lorenzo A Calò1, Silvia Schiavo, Paul A Davis, Elisa Pagnin, Paolo Mormino, Angela D'Angelo, Achille C Pessina.   

Abstract

BACKGROUND: ACE and ACE2 produce angiotensin II (Ang II), a vasopressor that induces cardiovascular remodeling, and Ang 1-7, a vasodilator with an antiremodeling effect. While Ang 1-7 has antiarrhythmic properties, at higher concentration it may induce ventricular tachycardia and sudden death. ACE2, therefore, may play an essential role in blood pressure homeostasis, in the long-term complications of hypertension (cardiovascular remodeling), and in the induction of cardiac electric abnormalities. This study evaluated the levels of ACE2 and Ang 1-7 in Bartter's/Gitelman's patients (BS/GS) who have elevated Ang II and endogenous blockade of Ang II type 1 receptor signaling compared with healthy subjects (C) and essential hypertensives (EH). BS/ GS patients were also considered because of their predisposition to cardiac arrhythmias, which has yet to be completely clarified.
METHODS: Mononuclear cell ACE2 and Ang 1-7 were evaluated using western blot.
RESULTS: One-way ANOVA showed that ACE2 and Ang 1-7 levels were significantly different between the three groups (p=0.0074 and p=0.0001, respectively). Post-hoc analysis (Tukey's HSD) showed that both ACE2 (1.59+/-0.63) and Ang1-7 (2.26+/-1.18) were significantly elevated in BS/GS compared with either C (0.98+/-0.45; p=0.008; 1.12+/-0.48, p=0.002, respectively) or EH (1.06+/-0.24; p=0.043; 0.72+/-0.28; p=0.0001, respectively). ACE2 and Ang 1-7 directly correlated only in BS/GS (r=0.91, p<0.0003).
CONCLUSIONS: The elevated ACE2 and Ang 1-7 in BS/ GS patients mirror those in hypertensives and are in line with the clinical, hemodynamic and pathophysiological characteristics of BS/GS, likely contributing to them. In consideration of the clinical picture of these syndromes, the opposite of hypertension, the results of this study further strengthen the importance of the ACE2/Ang 1-7 system in the regulation of vascular tone and cardiovascular biology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349406

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  15 in total

1.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

Review 2.  Gitelman syndrome: an analysis of the underlying pathophysiologic mechanisms of acid-base and electrolyte abnormalities.

Authors:  T D Filippatos; C V Rizos; E Tzavella; M S Elisaf
Journal:  Int Urol Nephrol       Date:  2017-07-25       Impact factor: 2.370

3.  Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence.

Authors:  Jiao-Lin Zheng; Guang-Ze Li; Shu-Zhen Chen; Jin-Ju Wang; James E Olson; Hui-Jing Xia; Eric Lazartigues; Yu-Lan Zhu; Yan-Fang Chen
Journal:  CNS Neurosci Ther       Date:  2014-03-02       Impact factor: 5.243

4.  Management of a severe case of Gitelman syndrome with poor response to standard treatment.

Authors:  Leila Koudsi; Stanka Nikolova; Vinita Mishra
Journal:  BMJ Case Rep       Date:  2016-02-17

5.  Gitelman syndrome and pregnancy.

Authors:  Michael N Moustakakis; Margarita Bockorny
Journal:  Clin Kidney J       Date:  2012-12

Review 6.  A systematic review to investigate whether Angiotensin-(1-7) is a promising therapeutic target in human heart failure.

Authors:  Vincent C H Lee; Elizabeth N Lloyd; Helena C Dearden; Kenneth Wong
Journal:  Int J Pept       Date:  2013-12-12

7.  Angiotensin II subtype 1a receptor signaling in resident hepatic macrophages induces liver metastasis formation.

Authors:  Yuki Shimizu; Hideki Amano; Yoshiya Ito; Tomohiro Betto; Sakiko Yamane; Tomoyoshi Inoue; Nobuyuki Nishizawa; Yoshio Matsui; Mariko Kamata; Masaki Nakamura; Hidero Kitasato; Wasaburo Koizumi; Masataka Majima
Journal:  Cancer Sci       Date:  2017-07-27       Impact factor: 6.716

8.  Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo.

Authors:  Seyoung Lee; Megan A Evans; Hannah X Chu; Hyun Ah Kim; Robert E Widdop; Grant R Drummond; Christopher G Sobey
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

9.  Gitelman syndrome: a rare life-threatening case of hypokalemic paralysis mimicking Guillain-Barré syndrome during pregnancy and review of the literature.

Authors:  Abdelghafour Elkoundi; Noureddine Kartite; Mustapha Bensghir; Nawfal Doghmi; Salim Jaafar Lalaoui
Journal:  Clin Case Rep       Date:  2017-08-17

Review 10.  Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome.

Authors:  Sonia Villapol
Journal:  Transl Res       Date:  2020-08-20       Impact factor: 10.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.